HealthCap IX Advisor

HealthCap is a European life-science VC backing therapeutics, medtech, and diagnostics from seed to clinical stage across the Nordic region and broader Europe.

HealthCap IX Advisor

HealthCap IX Advisor AB is an exempt reporting adviser in Stockholm.

linkedin.com/company/healthcap

General information

Firm type

Asset Manager

Location

Region

Europe

Country

Sweden

Sector focus

Life Sciences

What is HealthCap's investment focus?

HealthCap focuses on life-science investments across Europe, with an emphasis on novel therapeutics, medical technology, and diagnostics. The firm looks for science-driven opportunities addressing significant unmet medical needs, primarily in biopharma. Its geographic sweet spot is the Nordic region and the UK, though it invests across the continent.

How does HealthCap differ from generalist European VC firms?

HealthCap is a specialist, investing exclusively in life sciences rather than diversifying across technology sectors. This concentration allows it to maintain a deep scientific advisory network and a partnership team with domain expertise critical for evaluating early-stage drug development risk. Its funds are dedicated solely to healthcare, distinguishing it from broader tech or cleantech investors.

What stage of company does HealthCap typically back?

The firm is stage-agnostic within the life-science context, investing from seed and Series A for preclinical platforms through to later-stage, clinical-phase companies. Its fund structure allows it to support portfolio companies through the capital-intensive clinical trial process, reflecting a strategy that often begins at an early scientific stage and follows through beyond regulatory milestones.

Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: Aug 14, 2026. Continuous refresh with full update cycles at least every 30 days.